SION
Income statement / Annual
Last year (2024), Sionna Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Sionna Therapeutics, Inc.'s net income was -$61.69 M.
See Sionna Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$668.00 K
|
$0.00
|
$0.00
|
| Gross Profit |
-$668.00 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
| Research and Development Expenses |
$57.29 M
|
$40.63 M
|
$34.61 M
|
| General & Administrative Expenses |
$13.27 M
|
$9.71 M
|
$6.77 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.27 M
|
$9.71 M
|
$6.77 M
|
| Other Expenses |
-$668.00 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$69.89 M
|
$50.33 M
|
$41.37 M
|
| Cost And Expenses |
$70.56 M
|
$50.33 M
|
$41.37 M
|
| Interest Income |
$8.17 M
|
$2.77 M
|
$1.13 M
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$668.00 K
|
$583.00 K
|
$122.00 K
|
| EBITDA |
-$69.89 M |
-$49.75 M |
-$41.25 M |
| EBITDA Ratio |
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$8.87 M
|
$3.07 M
|
$1.13 M
|
| Income Before Tax |
-$61.69 M
|
-$47.26 M
|
-$40.24 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$61.69 M
|
-$47.26 M
|
-$40.24 M
|
| Net Income Ratio |
0
|
0
|
0
|
| EPS |
-1.4 |
-1.0711 |
-0.912 |
| EPS Diluted |
-1.4 |
-1.0711 |
-0.912 |
| Weighted Average Shares Out |
$44.12 M
|
$44.12 M
|
$44.12 M
|
| Weighted Average Shares Out Diluted |
$44.12 M
|
$44.12 M
|
$44.12 M
|
| Link |
|
|
|
